Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark van der Linden

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021Stephanie Perniciaro, Mark van der Linden, Daniel M Weinberger
BMC Infectious Diseases|January 21, 2010
Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infantsSimon Rückinger, Mark van der Linden, Rüdiger von Kries
International Journal of Medical Microbiology : IJMM|July 17, 2009
Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal statesMatthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Antimicrobial Agents|March 23, 2011
mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in GermanyChristine Bley, Mark van der Linden, Ralf René Reinert
International Journal of Medical Microbiology : IJMM|September 2, 2015
Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in GermanyMatthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Antimicrobial Agents|May 8, 2009
New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008)Matthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Microbiology|July 31, 2010
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008)Matthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Medical Microbiology : IJMM|January 15, 2010
Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008Matthias Imöhl, Ralf René Reinert, Mark van der Linden
Frontiers in Medicine|June 7, 2021
Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in GermanyMatthias Imöhl, Stephanie Perniciaro, Andreas Busse, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 2, 2017
PBP2a in β-Lactam-Resistant Laboratory Mutants and Clinical Isolates: Disruption Versus Reduced Penicillin AffinityMark van der Linden, Jens Rutschmann, Patrick Maurer, et al.
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2022
Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021Stephanie Perniciaro, Mark van der Linden, Daniel M Weinberger
BMC Infectious Diseases|January 21, 2010
Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infantsSimon Rückinger, Mark van der Linden, Rüdiger von Kries
International Journal of Medical Microbiology : IJMM|July 17, 2009
Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal statesMatthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Antimicrobial Agents|March 23, 2011
mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in GermanyChristine Bley, Mark van der Linden, Ralf René Reinert
International Journal of Medical Microbiology : IJMM|September 2, 2015
Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in GermanyMatthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Antimicrobial Agents|May 8, 2009
New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008)Matthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Microbiology|July 31, 2010
Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008)Matthias Imöhl, Ralf René Reinert, Mark van der Linden
International Journal of Medical Microbiology : IJMM|January 15, 2010
Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008Matthias Imöhl, Ralf René Reinert, Mark van der Linden
Frontiers in Medicine|June 7, 2021
Bacterial Spectrum of Spontaneously Ruptured Otitis Media in a 7-Year, Longitudinal, Multicenter, Epidemiological Cross-Sectional Study in GermanyMatthias Imöhl, Stephanie Perniciaro, Andreas Busse, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|December 2, 2017
PBP2a in β-Lactam-Resistant Laboratory Mutants and Clinical Isolates: Disruption Versus Reduced Penicillin AffinityMark van der Linden, Jens Rutschmann, Patrick Maurer, et al.
Pageof 14